These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16677798)

  • 21. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
    Iovine C; Lilli S; Gentile A; Patti L; Di Marino L; Cipriano P; Riccardi G; Rivellese AA
    Eur J Clin Invest; 2006 Aug; 36(8):560-5. PubMed ID: 16893378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus.
    van Greevenbroek MM; Vermeulen VM; Feskens EJ; Evelo CT; Kruijshoop M; Hoebee B; van der Kallen CJ; de Bruin TW
    Diabet Med; 2007 May; 24(5):498-504. PubMed ID: 17381501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus.
    Hogue JC; Lamarche B; Tremblay AJ; Bergeron J; Gagné C; Couture P
    Metabolism; 2008 Mar; 57(3):380-6. PubMed ID: 18249211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
    Pei D; Hsieh CH; Hung YJ; Li JC; Lee CH; Kuo SW
    Metabolism; 2006 Jul; 55(7):923-7. PubMed ID: 16784965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of different doses of atorvastatin on plasma endothelin-1 levels in type 2 diabetic patients with dyslipidemia.
    Lam HC; Chu CH; Wei MC; Keng HM; Lu CC; Sun CC; Lee JK; Chuang MJ; Wang MC; Tai MH
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1010-5. PubMed ID: 16741040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Improvements in insulin sensitivity and inflammatory markers are induced by pravastatin in nondiabetic subjects with hypercholesterolemia.
    Lee WJ; Lee WL; Tang YJ; Liang KW; Chien YH; Tsou SS; Sheu WH
    Clin Chim Acta; 2008 Apr; 390(1-2):49-55. PubMed ID: 18201563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects.
    Kotronen A; Juurinen L; Hakkarainen A; Westerbacka J; Cornér A; Bergholm R; Yki-Järvinen H
    Diabetes Care; 2008 Jan; 31(1):165-9. PubMed ID: 17934148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet nitric oxide production and IR: relation with obesity and hypertriglyceridemia.
    Vignini A; Nanetti L; Moroni C; Testa R; Sirolla C; Marra M; Cenerelli S; Gregori A; Fumelli D; Olivieri F; Mazzanti L; Rabini RA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):553-8. PubMed ID: 18155481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired triacylglycerol catabolism in hypertriglyceridemia of the diabetic, cholesterol-fed rabbit: a possible mechanism for protection from atherosclerosis.
    Minnich A; Zilversmit DB
    Biochim Biophys Acta; 1989 Apr; 1002(3):324-32. PubMed ID: 2713383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
    Karalis DG; Ishisaka DY; Luo D; Ntanios F; Wun CC
    Am J Cardiol; 2007 Aug; 100(3):445-9. PubMed ID: 17659926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of lipid changes among type 2 diabetes patients in Sudan.
    Elnasri HA; Ahmed AM
    East Mediterr Health J; 2008; 14(2):314-24. PubMed ID: 18561723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
    Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.
    Clifton PM; Bastiaans K; Keogh JB
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):548-54. PubMed ID: 19179060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides.
    Schulze F; Glos S; Petruschka D; Altenburg C; Maas R; Benndorf R; Schwedhelm E; Beil U; Böger RH
    Nutr Res; 2009 May; 29(5):291-7. PubMed ID: 19555809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.
    Huptas S; Geiss HC; Otto C; Parhofer KG
    Am J Cardiol; 2006 Jul; 98(1):66-9. PubMed ID: 16784923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased VLDL-Apo B 100 Fractional Synthesis Rate Despite Hypertriglyceridemia in Subjects With Type 2 Diabetes and Nephropathy.
    Tessari P; Kiwanuka E; Barazzoni R; Toffolo GM; Vettore M; Cortella I; Manesso E; Pasqualetto G; Puricelli L; Gabelli C; Zanetti M
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4098-105. PubMed ID: 26291068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ScrF I polymorphism in the 2nd intron of the HMGCR gene on lipid-lowering response to simvastatin in Chinese diabetic patients.
    Ying S; Sun YM; Liu XM; An CY; Gao YY
    Biochem Biophys Res Commun; 2007 Nov; 363(2):395-8. PubMed ID: 17870053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of short-term low- and high-carbohydrate diets on postprandial metabolism in non-diabetic and diabetic subjects.
    Culling KS; Neil HA; Gilbert M; Frayn KN
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):345-51. PubMed ID: 18083355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.